Establishment Labs Holdings Inc found using ticker (ESTA) now have 6 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 61 and 34 and has a mean target at 52.5. Given that the stocks previous close was at 54.94 this indicates there is a potential downside of -4.4%. There is a 50 day moving average of 45.04 and the 200 moving average now moves to 27.47. The company has a market capitalisation of $1,336m. Find out more information at: http://www.establishmentlabs.com
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in 80 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.